Clinical Trials Logo

Substance-Related Disorders clinical trials

View clinical trials related to Substance-Related Disorders.

Filter by:

NCT ID: NCT03665415 Not yet recruiting - Physical Activity Clinical Trials

Expanded Game Squad for Neurodiverse Youth

NDGameSquad
Start date: October 2018
Phase: N/A
Study type: Interventional

The proposed study will pilot the use of an adapted Game Squad intervention aimed at improving physical activity and other important health behaviors (nutrition, sleep hygiene, screen time habits) for children and adolescents receiving special education supports for behavioral health challenges, or who are served by the Boston Medical Center Developmental and Behavioral Pediatrics (BMC-DBP) clinic.

NCT ID: NCT03661580 Not yet recruiting - Depression Clinical Trials

BA Trial for Co-Occurring Depression and Substance Use

Start date: September 12, 2018
Phase: N/A
Study type: Interventional

A large proportion of people seeking treatment for drug and alcohol issues also have clinically significant depression symptoms. This combination of problems tends to have a negative impact on treatment and leads to poor health and disability, yet relatively few studies have focused on the development of interventions for treating this comorbidity. There is emerging evidence to suggest that Behavioural Activation (BA) may be a viable and cost-effective treatment for comorbid depression and substance use problems, however more research is needed in order to establish its effectiveness in routine practice. The aim of this study is therefore to investigate the efficacy of a brief (6-session), manualised BA intervention among service users with depression who are accessing Community Drugs and Alcohol treatment. We are planning to recruit up to 128 service users who are actively using substances to be randomly assigned to either the 6-week BA intervention or Treatment as Usual in Community Drugs and Alcohol services. These participants will be recruited from either a Community Drugs and Alcohol service or a Community Mental Health service. Our research will assess whether the BA intervention is more effective than usual care in (1) reducing depression symptoms, (2) reducing substance use, and (3) improving treatment engagement (i.e. session attendance). We expect that our results will establish the efficacy of integrating BA for depression into routine Community Drugs and Alcohol Treatment.

NCT ID: NCT03655574 Not yet recruiting - Substance Abuse Clinical Trials

Substance Use Interventions for Truant Adolescents

GOALS
Start date: October 1, 2018
Phase: N/A
Study type: Interventional

This study evaluates a brief motivation-building intervention for parents and teens to reduce truancy and substance use. It is hypothesized that the motivational intervention will result in better outcomes compared to an education-only intervention.

NCT ID: NCT03652311 Not yet recruiting - Clinical trials for Substance Use Disorders

Investigating the Efficacy of Caloric Vestibular Stimulation in the Treatment of Substance Use Disorders

Start date: September 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to determine efficacy and effect of CVS (caloric vestibular stimulation)

NCT ID: NCT03651453 Not yet recruiting - HIV Infections Clinical Trials

OPTIONS: A Patient-Centered HIV Prevention Decision Aid for PrEP Uptake for Women With Substance Use in Treatment Settings

Start date: September 1, 2018
Phase: N/A
Study type: Interventional

To develop and test the effect of a patient-centered HIV prevention decision aid on HIV pre-exposure prophylaxis (PrEP) uptake among women with substance use disorders (SUD) in treatment.

NCT ID: NCT03648684 Not yet recruiting - Clinical trials for Prescription Drug Abuse (Not Dependent)

Examining Expectancy Challenges to Prevent Nonmedical Prescription Stimulant Use

Start date: September 2018
Phase: N/A
Study type: Interventional

Nonmedical prescription stimulant use (NPS) is commonly reported among college students for cognitive enhancement purposes, though it is associated with numerous negative psychological and physical consequences. Despite increasingly high prevalence rates and widespread acknowledgement of the need for efficacious interventions, little is known regarding how to prevent or treat this behavior. An intervention that targets cognitive enhancement motives and expectancy effects related to NPS may be particularly effective in light of recent research purporting limited evidence for meaningful NPS-related cognitive improvements among individuals without legitimate attention deficits. The primary objective of this proposal is to examine the efficacy of an intervention that successfully prevents NPS among college students by modifying expectations for NPS-related effects, while at the same time providing alternative means of enhancing cognition and arousal. Participants will be 126 stimulant-naïve college students who report a combination of risk factors for NPS. They will be randomized to one of three treatment conditions: a placebo-based expectancy challenge intervention that solely aims to modify expectancies related to NPS, a caffeine-based expectancy challenge intervention that includes expectancy modification combined with a safer alternative for cognitive enhancement, or a control group. Multilevel mixed modeling and survival analyses will be used to 1) examine changes in NPS-related expectancy effects across a 6-month follow-up period, and 2) assess incidence of NPS over the follow-up period, respectively, across the three groups. It is hypothesized that both expectancy challenge interventions will successfully modify expectancies compared to the control group and that they will be maintained over the follow-up period. It is also expected that the caffeine-based intervention will most successfully prevent NPS through a combination of expectancy modification and encouraging safe use of caffeine rather than prescription stimulants to achieve desired outcomes. Mediational analyses will also be employed to assess whether changes in expectancy effects via the interventions are responsible for differences in initiation rates between groups. The results of this project will facilitate the development of larger-scale prevention efforts to target the high rate of NPS on college campuses.

NCT ID: NCT03644719 Completed - Clinical trials for Substance Use Disorders

Effectiveness of a Brief Cognitive and Behavioral Skills Program on Stage Transitions for Chronic Ketamine Abusers

Start date: August 19, 2014
Phase: N/A
Study type: Interventional

In recent years ketamine abuse becomes prevalent in youth in some Asian countries. Chronic ketamine abuse may lead to uropathology and cognitive impairments. No pharmacological interventions have been identified as effective for treating ketamine abuse or helpful in achieving or maintaining abstinence from ketamine. Cognitive-behavioral treatment is currently an important psychosocial intervention for addictive problems. This study aimed to test whether a brief cognitive-behavioral training program has a positive influence on stage transitions among ketamine abusers.

NCT ID: NCT03642379 Not yet recruiting - Clinical trials for Substance Use Disorders

Cardiac Surgery Peer Support Recovery

Start date: September 2018
Phase: N/A
Study type: Interventional

Develop and implementation an addiction recovery support program for cardiac surgery patients admitted with a diagnosis of infective endocarditis secondary to IV drug addiction.

NCT ID: NCT03630471 Not yet recruiting - Clinical trials for Mental Health Issue (E.G., Depression, Psychosis, Personality Disorder, Substance Abuse)

Effectiveness of a Problem-solving Intervention for Common Adolescent Mental Health Problems in India

PRIDE
Start date: September 1, 2018
Phase: N/A
Study type: Interventional

The objective of this study is to evaluate the effectiveness of a low-intensity, lay counsellor-delivered, problem-solving intervention for adolescents with common mental health problems attending Government-run secondary schools in New Delhi, India. The primary hypothesis is that the PRIDE intervention will be superior to an Enhanced Usual Care (EUC) control condition in reducing the severity of participating adolescents' self-reported mental health symptoms and idiographic problems at six weeks post-randomization. The secondary hypotheses are that the intervention will be superior to the control condition with respect to: - reduced self-reported adolescent mental health symptoms and idiographic problems at 12 weeks post-randomization - reduced parent-reported adolescent mental health symptoms at six and 12 weeks post-randomization - reduced self- and parent-reported distress/functional impairment for adolescents at six and 12 weeks post-randomization - reduced self-reported perceived stress for adolescents at six and 12 weeks post-randomization - improved self-reported adolescent wellbeing at six and 12 weeks post-randomization - improved remission rates derived from predetermined cut-offs for self-reported adolescent mental health symptoms and associated distress/functional impairment at six and 12 weeks post-randomization A process evaluation will be nested in the trial to provide findings that will assist in the interpretation of the trial results and to inform potential implementation of the PRIDE intervention on a wider scale.

NCT ID: NCT03628846 Recruiting - Opioid Use Clinical Trials

Opioid Use After Traumatic Injury in Adolescents

Start date: July 1, 2018
Phase:
Study type: Observational

The purpose of this study is to prospectively follow a cohort of traumatically injured adolescents to 1) Identify patient-reported factors for sustained prescription opioid use, including chronic pain and mental health conditions such as PTSD, depression, anxiety, and sleep disorders by longitudinally surveying injured adolescents; and 2) Assess clinical, behavioral, and social predictors of prescription opioid misuse and nonmedical opioid use.